Friedman Gregory K, Gillespie G Yancey
Division of Pediatric Hematology and Oncology, University of Alabama at Birmingham, Birmingham, AL 35233, USA.
Cancers (Basel). 2011 Jan 14;3(1):298-318. doi: 10.3390/cancers3010298.
Recently, a subpopulation of cells, termed tumor-initiating cells or tumor stem cells (TSC), has been identified in many different types of solid tumors. These TSC, which are typically more resistant to chemotherapy and radiation compared to other tumor cells, have properties similar to normal stem cells including multipotency and the ability to self-renew, proliferate, and maintain the neoplastic clone. Much of the research on TSC has focused on adult cancers. With considerable differences in tumor biology between adult and pediatric cancers, there may be significant differences in the presence, function and behavior of TSC in pediatric malignancies. We discuss what is currently known about pediatric solid TSC with specific focus on TSC markers, tumor microenvironment, signaling pathways, therapeutic resistance and potential future therapies to target pediatric TSC.
最近,在许多不同类型的实体瘤中发现了一类细胞亚群,称为肿瘤起始细胞或肿瘤干细胞(TSC)。与其他肿瘤细胞相比,这些TSC通常对化疗和放疗更具抗性,具有与正常干细胞相似的特性,包括多能性以及自我更新、增殖和维持肿瘤克隆的能力。关于TSC的许多研究都集中在成人癌症上。由于成人癌症和儿童癌症在肿瘤生物学方面存在相当大的差异,TSC在儿童恶性肿瘤中的存在、功能和行为可能存在显著差异。我们讨论目前关于儿童实体瘤TSC的已知情况,特别关注TSC标志物、肿瘤微环境、信号通路、治疗抗性以及未来针对儿童TSC的潜在治疗方法。